← Open Payments lookup

CASEY PROUGH: Open Payments

NPI 1396723706 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$109,229 in 286 payments from 20 companies in 2025. Trend: 2023 $110,607 · 2024 $119,392 · 2025 $109,229

Speaker / faculty: $97,525Food & beverage: $4,755Consulting: $3,520Travel & lodging: $3,429
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)97$55,340
ABBVIE INC.69$38,114
Otsuka America Pharmaceutical, Inc.20$9,328
E.R. Squibb & Sons, L.L.C.12$4,435
Neurocrine BioSciences, Inc.16$332
Janssen Pharmaceuticals, Inc12$299
Vanda Pharmaceuticals Inc.10$286
Alkermes, Inc.9$243
Teva Pharmaceuticals USA, Inc.12$221
Corium, LLC5$132

Products named: CAPLYTA, VRAYLAR, REXULTI, COBENFY, INGREZZA, SPRAVATO, ARISTADA, FANAPT.

Industry payments across MO — which companies pay providers there.